Advertisement
Advertisement
U.S. markets close in 6 hours
Advertisement
Advertisement
Advertisement
Advertisement

Avid Bioservices, Inc. (CDMO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
18.49+0.23 (+1.26%)
As of 10:00AM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Double Moving Average Crossover

Double Moving Average Crossover

Previous Close18.26
Open18.56
Bid18.50 x 800
Ask18.65 x 800
Day's Range18.40 - 18.93
52 Week Range11.30 - 34.51
Volume45,434
Avg. Volume577,274
Market Cap1.149B
Beta (5Y Monthly)2.16
PE Ratio (TTM)10.57
EPS (TTM)1.75
Earnings DateDec 05, 2022 - Dec 09, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est26.67
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
29% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for CDMO

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Avid Bioservices, Inc.
    CDMO: What does Argus have to say about CDMO?AVID BIOSERVICES INC has an Investment Rating of HOLD; a target price of $19.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Low; and a Value Subrating of Medium.
    Rating
    Fair Value
    Economic Moat
    7 days agoArgus Research
View more
  • GlobeNewswire

    Avid Bioservices to Participate in RBC Global CDMO Conference

    TUSTIN, Calif., Sept. 27, 2022 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced that the company will participate in the RBC Global CDMO Conference. Nick Green, president and chief executive officer, will be the featured speaker in a fireside chat a

  • GlobeNewswire

    Avid Bioservices Appoints Michael Alston, Jr. as Vice President, Operations

    Accomplished Operations Professional Promoted from Role as Director of Project Engineering; Credited with Leading All of the Company’s Ongoing Facility Expansion ProjectsTUSTIN, Calif., Sept. 22, 2022 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced

  • Simply Wall St.

    We Ran A Stock Scan For Earnings Growth And Avid Bioservices (NASDAQ:CDMO) Passed With Ease

    The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Advertisement
Advertisement